CAMBRIDGE,
Mass., May 16, 2024 /PRNewswire/ -- ConcertAI,
the leader in oncology predictive and generative AI SaaS Solutions
and Real-World Data for healthcare and life sciences, today
announced that Dhiraj Carumbaya has joined the company as Senior
Vice President and General Manager of the company's TeraRecon
business.
Dhiraj brings over two decades of domain and
industry experience in Medical Imaging, Healthcare Informatics, and
Clinical AI. He will lead ConcertAI's industry-leading advanced
visualization solution Intuition™, leading in class Eureka™
Clinical AI, a new product group focused on Imaging data solutions,
and a new group focused on advanced Generative AI innovations for
imaging interpretation and clinical research applications.
"Dhiraj started his career focused on Diagnostic
Imaging and directly running healthcare provider solutions using AI
– that was the key criterion we had for this leadership role," said
Jeff Elton, PhD, CEO of ConcertAI.
"His depth in imaging broadly, SaaS technologies, and AI, he is
uniquely suited to ensure our provider and biopharma partners have
the most advanced technologies and data to transform the diagnostic
and research experience. Over time, our customers will see benefits
from the company's leading work in precision oncology, and our
recently announced CARAai platform and TeraRecon imaging expertise
come together to advance evidence-based decision augmentations and
research solutions spanning translational sciences through clinical
development."
Dhiraj started as a researcher in medical
physics, progressed through healthcare providers, and managed
sizeable businesses at RadNet, Philips Healthcare, Amazon AWS, GE
Healthcare, and Fujifilm. At Philips, he doubled the
Radiology Informatics business in two years. At AWS, he
oversaw creating and scaling Amazon's next-generation cloud
solutions for the healthcare and life sciences industries. Before
that, he held global product and business leadership roles at GE
Healthcare. Dhiraj has also consulted for the US Government's
Accountability Office in Healthcare IT.
"Infusion of generative AI in medical imaging to
automate the segmentation of biomarkers, such as tumors from
high-fidelity medical images and biological diagnostics, is a
transformative experience for the healthcare providers and
biopharma industry," said Dhiraj. "I am excited to lead the
talented TeraRecon team as the company enters a new phase of growth
by bringing true innovations to our customers in medical diagnosis,
clinical research, and drug development."
About ConcertAI: ConcertAI is the
leader in Real-World Evidence (RWE) and AI technology solutions for
life sciences and health care. Our mission is to accelerate
insights and outcomes for patients through leading real-world data,
AI technologies, and scientific expertise in partnership with the
leading biomedical innovators, health care providers, and medical
societies. For more information, visit us
at www.concertai.com
About TeraRecon: Serving ~1,900
clinical sites globally, TeraRecon, a ConcertAI company, is a Best
in KLAS solution provider for AI-empowered radiology, oncology,
cardiology, neurology, and vascular surgery. Awarded the KLAS
Category Leader for Advanced Visualization, TeraRecon solutions are
independent of any one manufacturer's imaging equipment or PACS
system, allowing a single, unified, and simplified clinical
workflow that can improve efficiencies and deliver actionable
physician-guided insights. For more information, visit us
at www.terarecon.com
CONTACT: PR Contact – Nicole
Katzin, nicole@galestrategies.com
View original
content:https://www.prnewswire.com/news-releases/dhiraj-carumbaya-joins-concertai-as-senior-vice-president-and-general-manager-of-terarecon-302147206.html
SOURCE ConcertAI